Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Intel (INTC) Financials

Intel logo
$118.96 +8.16 (+7.36%)
Closing price 05/20/2026 04:00 PM Eastern
Extended Trading
$116.89 -2.07 (-1.74%)
As of 05/20/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Intel

Annual Income Statements for Intel

This table shows Intel's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/26/2015 12/31/2016 12/30/2017 12/29/2018 12/28/2019 12/26/2020 12/25/2021 12/31/2022 12/30/2023 12/28/2024 12/27/2025
Net Income / (Loss) Attributable to Common Shareholders		 11,420 10,316 9,601 21,053 21,048 20,899 19,868 8,014 1,689 -18,756 -267
Consolidated Net Income / (Loss)		 11,420 10,316 9,601 21,053 21,048 20,899 19,868 8,017 1,675 -19,233 26
Net Income / (Loss) Continuing Operations		 11,420 10,316 9,601 21,053 21,048 20,899 19,868 8,017 1,675 -19,233 26
Total Pre-Tax Income 		14,212 12,936 20,352 23,317 24,058 25,078 21,703 7,768 762 -11,210 1,557
Total Operating Income		 14,002 13,133 18,050 23,316 22,035 23,678 19,456 2,334 93 -11,678 -2,214
Total Gross Profit		 34,679 36,233 39,098 43,737 42,140 43,612 43,815 26,866 21,711 17,345 18,375
Total Revenue		 55,355 59,387 62,761 70,848 71,965 77,867 79,024 63,054 54,228 53,101 52,853
Operating Revenue		 55,355 59,387 62,761 70,848 71,965 77,867 79,024 63,054 54,228 53,101 52,853
Total Cost of Revenue		 20,676 23,154 23,663 27,111 29,825 34,255 35,209 36,188 32,517 35,756 34,478
Operating Cost of Revenue		 20,676 23,154 23,663 27,111 29,825 34,255 35,209 36,188 32,517 35,756 34,478
Total Operating Expenses		 20,677 23,100 21,048 20,421 20,105 19,934 24,359 24,532 21,618 29,023 20,589
Selling, General & Admin Expense		 7,930 8,377 7,452 6,950 6,350 6,180 6,543 7,002 5,634 5,507 4,624
Research & Development Expense		 12,128 12,685 13,035 13,543 13,362 13,556 15,190 17,528 16,046 16,546 13,774
Restructuring Charge		 354 1,744 384 -72 393 198 2,626 2.00 -62 6,970 2,191
Total Other Income / (Expense), net		 210 -197 2,302 1.00 2,023 1,400 2,247 5,434 669 468 3,771
Interest & Investment Income		 315 506 2,651 -125 1,539 1,904 2,729 4,268 40 242 514
Other Income / (Expense), net		 -105 -703 -349 126 484 -504 -482 1,166 629 226 3,257
Income Tax Expense		 2,792 2,620 10,751 2,264 3,010 4,179 1,835 -249 -913 8,023 1,531
Net Income / (Loss) Attributable to Noncontrolling Interest		 - - - - - 0.00 0.00 3.00 -14 -477 293
Basic Earnings per Share		 $2.41 $2.18 $2.04 $4.57 $4.77 $4.98 $4.89 $1.95 $0.40 ($4.38) ($0.06)
Weighted Average Basic Shares Outstanding		 4.74B 4.73B 4.70B 4.61B 4.42B 4.20B 4.06B 4.11B 4.19B 4.28B 4.53B
Diluted Earnings per Share		 $2.33 $2.12 $1.99 $4.48 $4.71 $4.94 $4.86 $1.94 $0.40 ($4.38) ($0.06)
Weighted Average Diluted Shares Outstanding		 4.89B 4.88B 4.84B 4.70B 4.47B 4.23B 4.09B 4.12B 4.21B 4.28B 4.53B
Weighted Average Basic & Diluted Shares Outstanding		 4.74B 4.73B 4.71B 4.61B 4.28B 8.13B 8.14B 8.27B 8.46B 4.33B 5.00B

Quarterly Income Statements for Intel

This table shows Intel's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025 3/28/2026
Net Income / (Loss) Attributable to Common Shareholders		 297 2,669 -381 -1,610 -16,639 -126 -821 -2,918 4,063 -591 -3,728
Consolidated Net Income / (Loss)		 310 2,660 -437 -1,654 -16,989 -153 -887 -3,024 4,270 -333 -4,281
Net Income / (Loss) Continuing Operations		 310 2,660 -437 -1,654 -16,989 -153 -887 -3,024 4,270 -333 -4,281
Total Pre-Tax Income 		-52 2,788 -719 -2,004 -9,086 599 -586 -2,769 4,574 338 -3,946
Total Operating Income		 -8.00 2,585 -1,069 -1,964 -9,057 412 -301 -3,176 683 580 -3,136
Total Gross Profit		 6,018 7,047 5,217 4,547 1,997 5,584 4,672 3,542 5,218 4,943 5,347
Total Revenue		 14,158 15,406 12,724 12,833 13,284 14,260 12,667 12,859 13,653 13,674 13,577
Operating Revenue		 14,158 15,406 12,724 12,833 13,284 14,260 12,667 12,859 13,653 13,674 13,577
Total Cost of Revenue		 8,140 8,359 7,507 8,286 11,287 8,676 7,995 9,317 8,435 8,731 8,230
Operating Cost of Revenue		 8,140 8,359 7,507 8,286 11,287 8,676 7,995 9,317 8,435 8,731 8,230
Total Operating Expenses		 6,026 4,462 6,286 6,511 11,054 5,172 4,973 6,718 4,535 4,363 8,483
Selling, General & Admin Expense		 1,340 1,617 1,556 1,329 1,383 1,239 1,177 1,144 1,129 1,174 1,038
Research & Development Expense		 3,870 3,987 4,382 4,239 4,049 3,876 3,640 3,684 3,231 3,219 3,375
Restructuring Charge		 816 -1,142 348 943 5,622 57 156 1,890 175 -30 4,070
Total Other Income / (Expense), net		 -44 203 350 -40 -29 187 -285 407 3,891 -242 -810
Interest & Investment Income		 -191 86 205 -120 -159 316 -112 502 221 -97 -72
Other Income / (Expense), net		 147 117 145 80 130 -129 -173 -95 3,670 -145 -738
Income Tax Expense		 -362 128 -282 -350 7,903 752 301 255 304 671 335
Net Income / (Loss) Attributable to Noncontrolling Interest		 13 -9.00 -56 -44 -350 -27 -66 -106 207 258 -553
Basic Earnings per Share		 $0.07 $0.64 ($0.09) ($0.38) ($3.88) ($0.03) ($0.19) ($0.67) $0.90 ($0.10) ($0.73)
Weighted Average Basic Shares Outstanding		 4.20B 4.19B 4.24B 4.27B 4.29B 4.28B 4.34B 4.37B 4.51B 4.53B 5.08B
Diluted Earnings per Share		 $0.07 $0.64 ($0.09) ($0.38) ($3.88) ($0.03) ($0.19) ($0.67) $0.90 ($0.10) ($0.73)
Weighted Average Diluted Shares Outstanding		 4.23B 4.21B 4.24B 4.27B 4.29B 4.28B 4.34B 4.37B 4.53B 4.53B 5.08B
Weighted Average Basic & Diluted Shares Outstanding		 4.22B 8.46B 4.26B 4.28B 4.31B 4.33B 4.36B 4.38B 4.77B 5.00B 5.03B

Annual Cash Flow Statements for Intel

This table details how cash moves in and out of Intel's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/26/2015 12/31/2016 12/30/2017 12/29/2018 12/28/2019 12/26/2020 12/25/2021 12/31/2022 12/30/2023 12/28/2024 12/27/2025
Net Change in Cash & Equivalents		 12,747 -9,748 -2,127 -414 1,175 1,671 -1,038 6,317 -4,065 1,170 6,463
Net Cash From Operating Activities		 19,018 21,808 22,110 29,432 33,145 35,864 29,456 15,433 11,471 8,288 9,697
Net Cash From Continuing Operating Activities		 19,018 21,808 22,110 29,432 33,145 35,864 29,456 15,433 11,471 8,288 9,697
Net Income / (Loss) Continuing Operations		 11,420 10,316 9,601 21,053 21,048 20,899 19,868 8,017 1,675 -19,233 26
Consolidated Net Income / (Loss)		 11,420 10,316 9,601 21,053 21,048 20,899 19,868 8,017 1,675 -19,233 26
Depreciation Expense		 7,821 6,266 6,752 7,520 9,204 10,482 9,953 11,128 7,847 9,951 10,757
Amortization Expense		 890 1,524 1,377 1,565 1,622 1,757 1,839 1,907 1,755 1,428 949
Non-Cash Adjustments To Reconcile Net Income		 1,396 1,012 -507 2,571 424 84 1,621 -810 2,796 8,907 -2,412
Changes in Operating Assets and Liabilities, net		 -2,509 2,690 4,887 -3,277 847 2,642 -3,825 -4,809 -2,602 7,235 377
Net Cash From Investing Activities		 -8,183 -25,817 -15,762 -11,239 -14,405 -21,524 -24,283 -10,231 -24,041 -18,256 -14,821
Net Cash From Continuing Investing Activities		 -8,183 -25,817 -15,762 -11,239 -14,405 -21,524 -24,283 -10,231 -24,041 -18,256 -14,821
Purchase of Property, Plant & Equipment		 -7,326 -9,625 -11,778 -15,181 -16,213 -14,259 -20,329 -24,844 -25,750 -23,944 -14,646
Acquisitions		 -913 -15,470 -14,499 -190 -1,958 - - -681 0.00 0.00 0.00
Purchase of Investments		 -21,755 -22,469 -18,065 -14,220 -11,952 -29,959 -41,167 -43,647 -44,414 -37,940 -24,319
Divestitures		 0.00 0.00 3,124 548 - 123 0.00 6,579 0.00 0.00 6,157
Sale and/or Maturity of Investments		 21,630 20,479 24,726 18,076 14,092 23,068 35,880 53,691 44,549 42,510 16,058
Other Investing Activities, net		 181 1,268 730 -272 1,626 -497 1,333 -1,329 1,574 1,118 1,929
Net Cash From Financing Activities		 1,912 -5,739 -8,475 -18,607 -17,565 -12,669 -6,211 1,115 8,505 11,138 11,587
Net Cash From Continuing Financing Activities		 1,912 -5,739 -8,475 -18,607 -17,565 -12,669 -6,211 1,115 8,505 11,138 11,587
Repayment of Debt		 -873 -2,069 -8,274 -3,314 -2,627 -4,016 -4,146 -1,833 -4,776 -2,130 -4,470
Repurchase of Common Equity		 -3,001 -2,587 -3,615 -10,730 -13,576 -14,229 -2,415 0.00 0.00 0.00 0.00
Payment of Dividends		 -4,556 -4,925 -5,072 -5,541 -5,576 -5,568 -5,644 -5,997 -3,088 -1,599 0.00
Issuance of Debt		 9,476 2,734 7,716 423 3,464 10,247 4,974 6,548 11,391 2,975 0.00
Issuance of Common Equity		 866 1,108 770 555 750 897 1,020 2,883 5,512 13,701 19,506
Other Financing Activities, net		 - - - - - 0.00 0.00 -486 -534 -1,809 -3,449
Cash Interest Paid		 186 682 624 448 469 594 545 459 613 987 1,106

Quarterly Cash Flow Statements for Intel

This table details how cash moves in and out of Intel's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025 3/28/2026
Net Change in Cash & Equivalents		 -728 -542 -156 4,364 -2,502 -536 698 746 1,448 3,571 2,983
Net Cash From Operating Activities		 5,824 4,624 -1,223 2,292 4,054 3,165 813 2,050 2,546 4,288 1,096
Net Cash From Continuing Operating Activities		 5,824 4,624 -1,223 2,292 4,054 3,165 813 2,050 2,546 4,288 1,096
Net Income / (Loss) Continuing Operations		 310 2,660 -437 -1,654 -16,989 -153 -887 -3,024 4,270 -333 -4,281
Consolidated Net Income / (Loss)		 310 2,660 -437 -1,654 -16,989 -153 -887 -3,024 4,270 -333 -4,281
Depreciation Expense		 2,020 2,094 2,200 2,203 3,248 2,300 2,425 2,788 2,758 2,786 2,902
Amortization Expense		 427 419 351 366 364 347 249 225 234 241 234
Non-Cash Adjustments To Reconcile Net Income		 1,341 -315 971 1,847 5,584 157 796 1,026 -5,055 821 4,658
Changes in Operating Assets and Liabilities, net		 1,726 -234 -4,308 -470 11,847 514 -1,770 1,035 339 773 -2,417
Net Cash From Investing Activities		 -7,394 -5,318 -2,563 -9,165 -2,764 -3,764 81 -2,086 -6,250 -6,566 3,093
Net Cash From Continuing Investing Activities		 -7,394 -5,318 -2,563 -9,165 -2,764 -3,764 81 -2,086 -6,250 -6,566 3,093
Purchase of Property, Plant & Equipment		 -5,753 -6,696 -5,970 -5,682 -6,458 -5,834 -5,183 -3,550 -2,425 -3,488 -3,636
Acquisitions		 - - - - - - 0.00 - - - -596
Purchase of Investments		 -11,591 -7,127 -6,460 -11,174 -13,885 -6,421 -3,386 -2,344 -10,671 -7,918 -7,190
Divestitures		 - - 0.00 - - - 1,935 - 4,251 -29 0.00
Sale and/or Maturity of Investments		 9,768 7,824 9,598 7,616 17,054 8,242 5,327 3,248 3,031 4,452 14,448
Other Investing Activities, net		 182 694 269 75 525 331 1,388 560 -436 417 67
Net Cash From Financing Activities		 842 152 3,630 11,237 -3,792 63 -196 782 5,152 5,849 -1,206
Net Cash From Continuing Financing Activities		 842 152 3,630 11,237 -3,792 63 -196 782 5,152 5,849 -1,206
Repayment of Debt		 -1,003 171 -220 -5,121 -5,573 8,784 -2,118 -1,556 -4,621 3,825 -2,370
Repurchase of Common Equity		 - - 0.00 - - - 0.00 - - - 0.00
Payment of Dividends		 -525 -527 -529 -534 -536 - 0.00 - - - 0.00
Issuance of Debt		 876 - 3,330 5,449 1,545 -7,349 1,496 1,997 - -3,493 0.00
Issuance of Common Equity		 1,222 2,052 626 5.00 355 12,715 491 - 4,945 14,070 427
Other Financing Activities, net		 272 -1,544 423 11,438 417 -14,087 -65 341 4,828 -8,553 737
Cash Interest Paid		 502 -50 540 -52 611 -112 635 -121 642 -50 600
Cash Income Taxes Paid		 129 972 315 1,240 325 322 221 1,572 146 - 261

Annual Balance Sheets for Intel

This table presents Intel's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/26/2015 12/31/2016 12/30/2017 12/29/2018 12/28/2019 12/26/2020 12/25/2021 12/31/2022 12/30/2023 12/28/2024 12/27/2025
Total Assets		 101,459 113,327 123,249 127,963 136,524 153,091 168,406 182,103 191,572 196,485 211,429
Total Current Assets		 38,320 35,508 29,500 28,787 31,239 47,249 58,558 50,407 43,269 47,324 63,688
Cash & Equivalents		 15,308 5,560 3,433 3,019 4,194 5,865 4,827 11,144 7,079 8,249 14,265
Short-Term Investments		 10,005 11,539 10,569 8,631 8,929 18,030 24,426 17,194 17,955 13,813 23,151
Accounts Receivable		 4,787 4,690 5,607 6,722 7,659 6,782 9,457 4,133 3,402 3,478 3,839
Inventories, net		 5,167 5,553 6,983 7,253 8,744 8,427 10,776 13,224 11,127 12,198 11,618
Other Current Assets		 2,982 2,956 2,908 3,162 1,713 2,745 2,130 4,712 3,706 9,586 10,815
Plant, Property, & Equipment, net		 31,858 36,171 41,109 48,976 55,386 56,584 63,245 80,860 96,647 107,919 105,414
Total Noncurrent Assets		 31,281 41,648 52,640 50,200 49,899 49,258 46,603 50,836 51,656 41,242 42,327
Long-Term Investments		 7,851 10,896 12,291 9,430 7,243 7,344 6,298 5,912 5,829 5,383 8,512
Goodwill		 11,332 14,099 24,389 24,513 26,276 26,971 26,963 27,591 27,591 24,693 23,912
Intangible Assets		 3,933 9,494 12,745 11,836 10,827 9,026 7,270 6,018 4,589 3,691 2,772
Other Noncurrent Operating Assets		 8,165 7,159 3,215 4,421 5,553 5,917 6,072 11,315 13,647 7,475 7,131
Total Liabilities & Shareholders' Equity		 101,459 113,327 123,249 127,963 136,524 153,091 168,406 182,103 191,572 196,485 211,429
Total Liabilities		 39,477 46,219 53,364 52,981 58,865 72,053 73,015 78,817 81,607 91,453 85,069
Total Current Liabilities		 15,646 20,302 17,421 16,626 22,310 24,754 27,462 32,155 28,053 35,666 31,575
Short-Term Debt		 2,634 4,634 1,776 1,261 3,693 2,504 4,591 4,367 2,288 3,729 2,499
Accounts Payable		 2,063 2,475 2,928 3,824 4,128 5,581 5,747 9,595 8,578 12,556 9,882
Current Deferred & Payable Income Tax Liabilities		 - - - - - - 1,076 2,251 1,107 1,756 0.00
Current Employee Benefit Liabilities		 3,138 3,465 3,526 3,622 3,853 3,999 4,535 4,084 3,655 3,343 3,990
Other Current Liabilities		 4,607 6,090 7,535 7,919 10,636 12,670 11,513 11,858 12,425 14,282 15,204
Total Noncurrent Liabilities		 23,831 25,917 35,943 36,355 36,555 47,299 45,553 46,662 53,554 55,787 53,494
Long-Term Debt		 20,036 20,649 25,037 25,098 25,308 33,897 33,510 37,684 46,978 46,282 44,086
Noncurrent Deferred Revenue		 - - 4,069 4,897 4,919 4,578 4,305 - - - 0.00
Other Noncurrent Operating Liabilities		 2,841 3,538 3,791 4,695 4,284 4,981 5,071 8,978 6,576 9,505 9,408
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 61,085 66,226 69,019 74,563 77,504 81,038 95,391 103,286 109,965 105,032 126,360
Total Preferred & Common Equity		 61,085 66,226 69,019 74,563 77,504 81,038 95,391 101,423 105,590 99,270 114,281
Total Common Equity		 61,085 66,226 69,019 74,563 77,504 81,038 95,391 101,423 105,590 99,270 114,281
Common Stock		 23,411 25,373 26,074 25,365 25,261 25,556 28,006 31,580 36,649 50,949 65,185
Retained Earnings		 37,614 40,747 42,083 50,172 53,523 56,233 68,265 70,405 69,156 49,032 48,983
Accumulated Other Comprehensive Income / (Loss)		 60 106 862 -974 -1,280 -751 -880 -562 -215 -711 113
Noncontrolling Interest		 - - - - - - 0.00 1,863 4,375 5,762 12,079

Quarterly Balance Sheets for Intel

This table presents Intel's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 7/1/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 3/28/2026
Total Assets		 185,629 188,837 191,572 192,733 206,205 193,542 196,485 192,242 192,520 204,514 205,332
Total Current Assets		 43,356 43,811 43,269 42,608 50,829 46,137 47,324 42,134 43,375 51,731 62,157
Cash & Equivalents		 8,349 7,621 7,079 6,923 11,287 8,785 8,249 8,947 9,643 11,141 17,247
Short-Term Investments		 15,908 17,409 17,955 14,388 17,986 15,301 13,813 12,101 11,563 19,794 15,542
Accounts Receivable		 2,996 2,843 3,402 3,323 3,131 3,121 3,478 3,064 2,360 3,202 4,066
Inventories, net		 11,984 11,466 11,127 11,494 11,244 12,062 12,198 12,281 11,377 11,489 12,426
Other Current Assets		 4,119 4,472 3,706 6,480 7,181 6,868 9,586 5,741 8,432 6,105 12,876
Plant, Property, & Equipment, net		 90,945 93,352 96,647 99,924 103,398 104,248 107,919 109,763 109,510 105,047 104,458
Total Noncurrent Assets		 51,328 51,674 51,656 50,201 51,978 43,157 41,242 40,345 39,635 47,736 38,717
Long-Term Investments		 5,893 5,700 5,829 6,139 5,824 5,496 5,383 5,027 5,383 8,667 8,481
Goodwill		 27,591 27,591 27,591 27,440 27,442 24,680 24,693 24,693 23,912 23,912 20,465
Intangible Assets		 5,173 4,970 4,589 4,675 4,383 3,975 3,691 3,568 3,057 2,877 2,722
Other Noncurrent Operating Assets		 12,671 13,413 13,647 11,947 14,329 9,006 7,475 7,057 7,283 12,280 7,049
Total Liabilities & Shareholders' Equity		 185,629 188,837 191,572 192,733 206,205 193,542 196,485 192,242 192,520 204,514 205,332
Total Liabilities		 81,158 83,151 81,607 81,977 85,771 88,678 91,453 85,829 86,769 87,784 80,343
Total Current Liabilities		 27,180 28,614 28,053 27,213 32,027 35,159 35,666 32,174 34,966 32,297 26,885
Short-Term Debt		 2,711 2,288 2,288 4,581 4,695 3,765 3,729 5,240 6,731 2,496 2,004
Accounts Payable		 8,757 8,669 8,578 8,559 9,618 11,074 12,556 10,896 10,666 10,268 7,159
Current Deferred & Payable Income Tax Liabilities		 2,169 2,112 1,107 346 1,856 2,440 1,756 1,873 887 825 0.00
Current Employee Benefit Liabilities		 2,887 3,115 3,655 2,506 2,651 5,015 3,343 2,652 4,249 3,756 2,824
Other Current Liabilities		 10,656 12,430 12,425 11,221 13,207 12,865 14,282 11,513 12,433 14,952 14,898
Total Noncurrent Liabilities		 53,978 54,537 53,554 54,764 53,744 53,519 55,787 53,655 51,803 55,487 53,458
Long-Term Debt		 46,335 46,591 46,978 47,869 48,334 46,471 46,282 44,911 44,026 44,057 43,027
Noncurrent Deferred Revenue		 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00
Other Noncurrent Operating Liabilities		 7,643 7,946 6,576 6,895 5,410 7,048 9,505 8,744 7,777 11,430 10,431
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 104,471 105,686 109,965 110,756 120,434 104,864 105,032 106,413 105,751 116,730 124,989
Total Preferred & Common Equity		 101,017 101,813 105,590 105,973 115,229 99,532 99,270 99,756 97,883 106,376 111,394
Total Common Equity		 101,017 101,813 105,590 105,973 115,229 99,532 99,270 99,756 97,883 106,376 111,394
Common Stock		 34,330 35,653 36,649 38,291 49,763 50,665 50,949 51,920 52,334 56,755 66,259
Retained Earnings		 67,231 67,021 69,156 68,224 66,162 49,052 49,032 48,322 45,484 49,602 45,179
Accumulated Other Comprehensive Income / (Loss)		 -544 -861 -215 -542 -696 -185 -711 -486 65 19 -44
Noncontrolling Interest		 3,454 3,873 4,375 4,783 5,205 5,332 5,762 6,657 7,868 10,354 13,595

Annual Metrics And Ratios for Intel

This table displays calculated financial ratios and metrics derived from Intel's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/26/2015 12/31/2016 12/30/2017 12/29/2018 12/28/2019 12/26/2020 12/25/2021 12/31/2022 12/30/2023 12/28/2024 12/27/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -0.92% 7.28% 5.68% 12.89% 1.58% 8.20% 1.49% -20.21% -14.00% -2.08% -0.47%
EBITDA Growth		 -5.56% -10.56% 27.74% 25.93% 2.51% 6.20% -13.12% -46.26% -37.56% -100.71% 17,564.38%
EBIT Growth		 -9.70% -10.56% 42.41% 32.43% -3.94% 2.91% -18.12% -81.55% -79.37% -1,686.15% 109.11%
NOPAT Growth		 -1.02% -6.92% -18.70% 147.23% -8.43% 2.36% -9.74% -86.48% -91.51% -4,098.75% 99.55%
Net Income Growth		 -2.43% -9.67% -6.93% 119.28% -0.02% -0.71% -4.93% -59.65% -79.11% -1,248.24% 100.14%
EPS Growth		 0.87% -9.01% -6.13% 125.13% 5.13% 4.88% -1.62% -60.08% -79.38% -1,195.00% 98.63%
Operating Cash Flow Growth		 -6.86% 14.67% 1.38% 33.12% 12.62% 8.20% -17.87% -47.61% -25.67% -27.75% 17.00%
Free Cash Flow Firm Growth		 -12.38% -88.06% -193.32% 1,528.14% 18.30% 90.46% -69.83% -332.25% 3.41% 56.64% 107.35%
Invested Capital Growth		 8.92% 18.71% 15.22% 14.00% 7.52% -6.37% 12.62% 22.08% 15.56% -0.60% -0.46%
Revenue Q/Q Growth		 0.35% 2.52% -0.93% 4.23% 2.20% -0.30% 0.70% -9.33% 2.58% -2.11% -1.10%
EBITDA Q/Q Growth		 -1.25% -2.10% -0.74% 8.18% 5.71% -4.37% -2.81% -25.31% 39.25% -103.30% 4.35%
EBIT Q/Q Growth		 -1.83% -1.72% -2.23% 9.87% 6.26% -6.67% -4.82% -62.43% 124.38% -26.78% 17.06%
NOPAT Q/Q Growth		 0.97% 2.24% -39.27% 59.78% 0.45% -6.19% -0.47% -70.53% 108.06% -22.86% 86.30%
Net Income Q/Q Growth		 -0.42% -0.49% -37.41% 53.88% 8.84% -4.78% -5.85% -39.73% 201.76% -17.13% -87.38%
EPS Q/Q Growth		 0.43% 0.47% -37.62% 54.48% 10.56% -2.95% -5.63% -40.31% 195.24% -18.06% -700.00%
Operating Cash Flow Q/Q Growth		 0.52% 15.10% -3.95% -1.15% 9.91% 1.36% -14.43% 17.51% -21.16% -14.97% 13.10%
Free Cash Flow Firm Q/Q Growth		 12.80% 15.74% 50.99% -17.93% 12.99% 43.23% -51.23% -25.89% -10.88% 11.18% -65.28%
Invested Capital Q/Q Growth		 1.13% 1.14% -7.41% 6.20% 3.91% -6.55% 2.53% 0.10% 3.66% 1.66% 2.70%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 62.65% 61.01% 62.30% 61.73% 58.56% 56.01% 55.45% 42.61% 40.04% 32.66% 34.77%
EBITDA Margin		 40.84% 34.05% 41.16% 45.91% 46.34% 45.48% 38.93% 26.22% 19.04% -0.14% 24.12%
Operating Margin		 25.29% 22.11% 28.76% 32.91% 30.62% 30.41% 24.62% 3.70% 0.17% -21.99% -4.19%
EBIT Margin		 25.11% 20.93% 28.20% 33.09% 31.29% 29.76% 24.01% 5.55% 1.33% -21.57% 1.97%
Profit (Net Income) Margin		 20.63% 17.37% 15.30% 29.72% 29.25% 26.84% 25.14% 12.71% 3.09% -36.22% 0.05%
Tax Burden Percent		 80.35% 79.75% 47.17% 90.29% 87.49% 83.34% 91.54% 103.21% 219.82% 171.57% 1.67%
Interest Burden Percent		 102.27% 104.07% 114.98% 99.47% 106.83% 108.22% 114.38% 221.94% 105.54% 97.89% 149.28%
Effective Tax Rate		 19.65% 20.25% 52.83% 9.71% 12.51% 16.66% 8.46% -3.21% -119.82% 0.00% 98.33%
Return on Invested Capital (ROIC)		 22.79% 18.61% 12.95% 27.95% 23.15% 23.62% 20.73% 2.38% 0.17% -6.39% -0.03%
ROIC Less NNEP Spread (ROIC-NNEP)		 21.11% 20.51% -26.67% 27.98% 48.59% 51.41% -68.12% 331.41% 11.39% -60.37% 0.51%
Return on Net Nonoperating Assets (RNNOA)		 -3.56% -2.62% 1.07% 1.12% 4.43% 2.72% 1.79% 5.69% 1.40% -11.50% 0.05%
Return on Equity (ROE)		 19.23% 15.98% 14.02% 29.07% 27.58% 26.34% 22.52% 8.07% 1.57% -17.89% 0.02%
Cash Return on Invested Capital (CROIC)		 14.25% 1.49% -1.19% 14.86% 15.90% 30.19% 8.86% -17.50% -14.26% -5.79% 0.43%
Operating Return on Assets (OROA)		 14.37% 11.57% 14.96% 18.66% 17.03% 16.00% 11.80% 2.00% 0.39% -5.90% 0.51%
Return on Assets (ROA)		 11.81% 9.61% 8.12% 16.76% 15.92% 14.43% 12.36% 4.57% 0.90% -9.91% 0.01%
Return on Common Equity (ROCE)		 18.94% 15.76% 13.84% 28.81% 27.47% 26.31% 22.52% 7.99% 1.53% -17.05% 0.02%
Return on Equity Simple (ROE_SIMPLE)		 18.70% 15.58% 13.91% 28.24% 27.16% 25.79% 20.83% 7.90% 1.59% -19.37% 0.00%
Net Operating Profit after Tax (NOPAT)		 11,251 10,473 8,515 21,052 19,278 19,732 17,811 2,409 204 -8,175 -37
NOPAT Margin		 20.33% 17.64% 13.57% 29.71% 26.79% 25.34% 22.54% 3.82% 0.38% -15.39% -0.07%
Net Nonoperating Expense Percent (NNEP)		 1.69% -1.90% 39.62% -0.03% -25.44% -27.79% 88.86% -329.02% -11.22% 53.98% -0.54%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 1.66% 0.13% -5.27% -0.02%
Cost of Revenue to Revenue		 37.35% 38.99% 37.70% 38.27% 41.44% 43.99% 44.55% 57.39% 59.96% 67.34% 65.23%
SG&A Expenses to Revenue		 14.33% 14.11% 11.87% 9.81% 8.82% 7.94% 8.28% 11.10% 10.39% 10.37% 8.75%
R&D to Revenue		 21.91% 21.36% 20.77% 19.12% 18.57% 17.41% 19.22% 27.80% 29.59% 31.16% 26.06%
Operating Expenses to Revenue		 37.35% 38.90% 33.54% 28.82% 27.94% 25.60% 30.82% 38.91% 39.87% 54.66% 38.96%
Earnings before Interest and Taxes (EBIT)		 13,897 12,430 17,701 23,442 22,519 23,174 18,974 3,500 722 -11,452 1,043
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 22,608 20,220 25,830 32,527 33,345 35,413 30,766 16,535 10,324 -73 12,749
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.14 2.12 2.63 2.46 2.97 2.15 2.03 1.04 1.98 0.88 1.51
Price to Tangible Book Value (P/TBV)		 2.85 3.29 5.69 4.81 5.71 3.87 3.16 1.55 2.85 1.24 1.97
Price to Revenue (P/Rev)		 2.36 2.36 2.89 2.59 3.20 2.24 2.45 1.67 3.86 1.65 3.27
Price to Earnings (P/E)		 11.42 13.60 18.89 8.72 10.95 8.34 9.74 13.12 123.77 0.00 0.00
Dividend Yield		 3.47% 3.51% 2.78% 2.98% 2.38% 3.10% 2.92% 5.73% 1.49% 2.46% 0.00%
Earnings Yield		 8.75% 7.35% 5.29% 11.46% 9.13% 11.98% 10.27% 7.62% 0.81% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 2.35 2.27 2.60 2.36 2.77 2.22 2.15 1.03 1.81 0.91 1.46
Enterprise Value to Revenue (EV/Rev)		 2.18 2.33 2.91 2.67 3.33 2.31 2.48 1.82 4.28 2.18 3.51
Enterprise Value to EBITDA (EV/EBITDA)		 5.35 6.85 7.08 5.82 7.18 5.07 6.37 6.95 22.46 0.00 14.54
Enterprise Value to EBIT (EV/EBIT)		 8.70 11.14 10.32 8.08 10.63 7.75 10.33 32.81 321.10 0.00 177.77
Enterprise Value to NOPAT (EV/NOPAT)		 10.74 13.22 21.46 8.99 12.41 9.10 11.01 47.68 1,134.05 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 6.36 6.35 8.27 6.43 7.22 5.01 6.66 7.44 20.21 13.98 19.12
Enterprise Value to Free Cash Flow (EV/FCFF)		 17.18 164.87 0.00 16.91 18.07 7.12 25.76 0.00 0.00 0.00 340.81
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.37 0.38 0.38 0.35 0.37 0.45 0.40 0.41 0.45 0.48 0.37
Long-Term Debt to Equity		 0.32 0.31 0.36 0.33 0.33 0.42 0.35 0.36 0.43 0.44 0.35
Financial Leverage		 -0.17 -0.13 -0.04 0.04 0.09 0.05 -0.03 0.02 0.12 0.19 0.10
Leverage Ratio		 1.63 1.66 1.73 1.73 1.73 1.83 1.82 1.76 1.75 1.80 1.76
Compound Leverage Factor		 1.67 1.73 1.99 1.72 1.85 1.97 2.08 3.92 1.85 1.77 2.63
Debt to Total Capital		 26.78% 27.37% 27.73% 26.01% 27.19% 31.00% 28.54% 28.93% 30.94% 32.26% 26.94%
Short-Term Debt to Total Capital		 3.11% 5.02% 1.84% 1.24% 3.46% 2.13% 3.44% 3.00% 1.44% 2.41% 1.45%
Long-Term Debt to Total Capital		 23.67% 22.35% 25.89% 24.77% 23.73% 28.86% 25.10% 25.93% 29.50% 29.85% 25.49%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 1.06% 0.95% 0.90% 0.41% 0.15% 0.00% 0.00% 1.28% 2.75% 3.72% 6.98%
Common Equity to Total Capital		 72.16% 71.68% 71.38% 73.58% 72.66% 69.00% 71.46% 69.78% 66.31% 64.03% 66.08%
Debt to EBITDA		 1.00 1.25 1.04 0.81 0.87 1.03 1.24 2.54 4.77 -685.08 3.65
Net Debt to EBITDA		 -0.46 -0.13 0.02 0.16 0.26 0.15 0.08 0.47 1.78 -309.12 0.05
Long-Term Debt to EBITDA		 0.89 1.02 0.97 0.77 0.76 0.96 1.09 2.28 4.55 -634.00 3.46
Debt to NOPAT		 2.01 2.41 3.15 1.25 1.50 1.84 2.14 17.46 240.99 -6.12 -1,260.04
Net Debt to NOPAT		 -0.93 -0.26 0.06 0.25 0.45 0.26 0.14 3.24 90.02 -2.76 -17.77
Long-Term Debt to NOPAT		 1.78 1.97 2.94 1.19 1.31 1.72 1.88 15.64 229.80 -5.66 -1,192.45
Altman Z-Score		 3.77 3.37 3.62 3.90 4.05 3.15 3.22 1.87 2.43 1.07 1.99
Noncontrolling Interest Sharing Ratio		 1.52% 1.38% 1.28% 0.89% 0.38% 0.10% 0.00% 0.94% 2.93% 4.71% 7.71%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.45 1.75 1.69 1.73 1.40 1.91 2.13 1.57 1.54 1.33 2.02
Quick Ratio		 1.92 1.07 1.13 1.11 0.93 1.24 1.41 1.01 1.01 0.72 1.31
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 7,036 840 -784 11,196 13,245 25,226 7,612 -17,679 -17,077 -7,405 544
Operating Cash Flow to CapEx		 259.60% 226.58% 187.72% 193.87% 204.43% 251.52% 144.90% 62.12% 44.55% 34.61% 66.21%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.57 0.55 0.53 0.56 0.54 0.54 0.49 0.36 0.29 0.27 0.26
Accounts Receivable Turnover		 12.02 12.53 12.19 11.49 10.01 10.78 9.73 9.28 14.39 15.44 14.45
Inventory Turnover		 4.38 4.32 3.78 3.81 3.73 3.99 3.67 3.02 2.67 3.07 2.90
Fixed Asset Turnover		 1.70 1.75 1.62 1.57 1.38 1.39 1.32 0.88 0.61 0.52 0.50
Accounts Payable Turnover		 8.60 10.20 8.76 8.03 7.50 7.06 6.22 4.72 3.58 3.38 3.07
Days Sales Outstanding (DSO)		 30.38 29.12 29.94 31.76 36.47 33.85 37.50 39.33 25.36 23.65 25.27
Days Inventory Outstanding (DIO)		 83.32 84.50 96.68 95.83 97.89 91.48 99.54 121.03 136.67 119.05 126.06
Days Payable Outstanding (DPO)		 42.47 35.77 41.67 45.45 48.66 51.73 58.72 77.37 102.00 107.87 118.77
Cash Conversion Cycle (CCC)		 71.24 77.85 84.96 82.14 85.70 73.60 78.32 83.00 60.03 34.83 32.56
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 51,473 61,106 70,405 80,261 86,294 80,800 90,999 111,087 128,368 127,598 127,017
Invested Capital Turnover		 1.12 1.06 0.95 0.94 0.86 0.93 0.92 0.62 0.45 0.41 0.42
Increase / (Decrease) in Invested Capital		 4,215 9,633 9,299 9,856 6,033 -5,494 10,199 20,088 17,281 -770 -581
Enterprise Value (EV)		 120,870 138,504 182,748 189,333 239,331 179,548 196,092 114,844 231,832 115,882 185,410
Market Capitalization		 130,467 140,334 181,362 183,635 230,541 174,386 193,542 105,180 209,054 87,554 172,674
Book Value per Share		 $12.94 $13.97 $14.75 $16.34 $17.82 $19.78 $23.45 $24.58 $25.05 $23.02 $23.96
Tangible Book Value per Share		 $9.71 $9.00 $6.81 $8.37 $9.29 $10.99 $15.04 $16.43 $17.41 $16.44 $18.36
Total Capital		 84,652 92,391 96,698 101,341 106,660 117,439 133,492 145,337 159,231 155,043 172,945
Total Debt		 22,670 25,283 26,813 26,359 29,001 36,401 38,101 42,051 49,266 50,011 46,585
Total Long-Term Debt		 20,036 20,649 25,037 25,098 25,308 33,897 33,510 37,684 46,978 46,282 44,086
Net Debt		 -10,494 -2,712 520 5,279 8,635 5,162 2,550 7,801 18,403 22,566 657
Capital Expenditures (CapEx)		 7,326 9,625 11,778 15,181 16,213 14,259 20,329 24,844 25,750 23,944 14,646
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -5.00 2,741 -147 1,772 -501 1,104 6,434 -5,719 -7,530 -6,675 -2,804
Debt-free Net Working Capital (DFNWC)		 25,308 19,840 13,855 13,422 12,622 24,999 35,687 22,619 17,504 15,387 34,612
Net Working Capital (NWC)		 22,674 15,206 12,079 12,161 8,929 22,495 31,096 18,252 15,216 11,658 32,113
Net Nonoperating Expense (NNE)		 -169 157 -1,086 -0.90 -1,770 -1,167 -2,057 -5,608 -1,471 11,058 -63
Net Nonoperating Obligations (NNO)		 -10,509 -6,002 520 5,279 8,635 -238 -4,392 7,801 18,403 22,566 657
Total Depreciation and Amortization (D&A)		 8,711 7,790 8,129 9,085 10,826 12,239 11,792 13,035 9,602 11,379 11,706
Debt-free, Cash-free Net Working Capital to Revenue		 -0.01% 4.62% -0.23% 2.50% -0.70% 1.42% 8.14% -9.07% -13.89% -12.57% -5.31%
Debt-free Net Working Capital to Revenue		 45.72% 33.41% 22.08% 18.94% 17.54% 32.10% 45.16% 35.87% 32.28% 28.98% 65.49%
Net Working Capital to Revenue		 40.96% 25.60% 19.25% 17.16% 12.41% 28.89% 39.35% 28.95% 28.06% 21.95% 60.76%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.41 $2.18 $2.04 $4.57 $4.77 $4.98 $4.89 $1.95 $0.40 ($4.38) ($0.06)
Adjusted Weighted Average Basic Shares Outstanding		 4.74B 4.73B 4.70B 4.61B 4.42B 4.20B 4.06B 4.11B 4.19B 4.28B 4.53B
Adjusted Diluted Earnings per Share		 $2.33 $2.12 $1.99 $4.48 $4.71 $4.94 $4.86 $1.94 $0.40 ($4.38) ($0.06)
Adjusted Weighted Average Diluted Shares Outstanding		 4.89B 4.88B 4.84B 4.70B 4.47B 4.23B 4.09B 4.12B 4.21B 4.28B 4.53B
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $4.77 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 4.72B 4.73B 4.67B 4.50B 4.28B 8.13B 8.14B 8.27B 8.46B 4.33B 5.00B
Normalized Net Operating Profit after Tax (NOPAT)		 11,536 11,864 12,904 20,987 19,622 19,897 20,215 1,635 22 -3,296 -16
Normalized NOPAT Margin		 20.84% 19.98% 20.56% 29.62% 27.27% 25.55% 25.58% 2.59% 0.04% -6.21% -0.03%
Pre Tax Income Margin		 25.67% 21.78% 32.43% 32.91% 33.43% 32.21% 27.46% 12.32% 1.41% -21.11% 2.95%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 39.89% 47.74% 52.83% 26.32% 26.49% 26.64% 28.41% 74.80% 184.36% -8.31% 0.00%
Augmented Payout Ratio		 66.17% 72.82% 90.48% 77.29% 90.99% 94.73% 40.56% 74.80% 184.36% -8.31% 0.00%

Quarterly Metrics And Ratios for Intel

This table displays calculated financial ratios and metrics derived from Intel's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025 3/28/2026
DEI Shares Outstanding		 - - - - - - - - - - 4,995,000,000.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 4,995,000,000.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - -0.75
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -7.69% 9.71% 8.61% -0.90% -6.17% -7.44% -0.45% 0.20% 2.78% -4.11% 7.18%
EBITDA Growth		 -19.56% 126.25% 56.59% -53.84% -305.53% -43.82% 35.22% -137.66% 238.19% 18.16% -133.55%
EBIT Growth		 475.68% 375.15% 30.37% -137.88% -6,522.30% -89.53% 48.70% -73.62% 148.76% 53.71% -717.30%
NOPAT Growth		 95.43% 411.25% 27.18% -93.31% -113,112.50% -104.27% 71.84% -61.71% 110.06% -442.99% -941.86%
Net Income Growth		 -69.58% 502.42% 84.21% -212.29% -5,580.32% -105.75% -102.97% -82.83% 125.13% -117.65% -382.64%
EPS Growth		 -72.00% 455.56% 86.36% -208.57% -5,642.86% -104.69% -111.11% -76.32% 123.20% -233.33% -284.21%
Operating Cash Flow Growth		 465.44% -39.97% 31.48% -18.38% -30.39% -31.55% 166.48% -10.56% -37.20% 35.48% 34.81%
Free Cash Flow Firm Growth		 42.39% 29.05% 13.78% 19.75% 37.66% 104.49% 126.08% 138.01% 130.84% -98.56% -109.02%
Invested Capital Growth		 11.59% 15.56% 15.92% 12.16% 1.36% -0.60% -3.88% -6.10% -1.46% -0.46% -1.33%
Revenue Q/Q Growth		 9.34% 8.81% -17.41% 0.86% 3.51% 7.35% -11.17% 1.52% 6.17% 0.15% -0.71%
EBITDA Q/Q Growth		 74.26% 101.66% -68.80% -57.90% -875.91% 155.13% -24.91% -111.73% 2,946.90% -52.87% -121.32%
EBIT Q/Q Growth		 117.55% 1,843.88% -134.20% -103.90% -373.83% 103.17% -267.49% -590.08% 233.08% -90.01% -990.57%
NOPAT Q/Q Growth		 99.21% 44,141.43% -130.34% -83.72% -361.15% 98.34% -100.22% -955.15% 128.68% -189.62% -284.17%
Net Income Q/Q Growth		 -78.95% 758.06% -116.43% -278.49% -927.15% 99.10% -479.74% -240.92% 241.20% -107.80% -1,185.59%
EPS Q/Q Growth		 -80.00% 814.29% -114.06% -322.22% -921.05% 99.23% -533.33% -252.63% 234.33% -111.11% -630.00%
Operating Cash Flow Q/Q Growth		 107.41% -20.60% -126.45% 287.41% 76.88% -21.93% -74.31% 152.15% 24.20% 68.42% -74.44%
Free Cash Flow Firm Q/Q Growth		 36.92% -15.11% -30.89% 15.56% 51.00% 108.29% 660.62% 23.09% -60.24% -99.61% -4,862.06%
Invested Capital Q/Q Growth		 0.38% 3.66% 5.76% 1.92% -9.29% 1.66% 2.27% -0.44% -4.80% 2.70% 1.36%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 42.51% 45.74% 41.00% 35.43% 15.03% 39.16% 36.88% 27.54% 38.22% 36.15% 39.38%
EBITDA Margin		 18.27% 33.85% 12.79% 5.34% -40.01% 20.55% 17.37% -2.01% 53.80% 25.32% -5.44%
Operating Margin		 -0.06% 16.78% -8.40% -15.30% -68.18% 2.89% -2.38% -24.70% 5.00% 4.24% -23.10%
EBIT Margin		 0.98% 17.54% -7.26% -14.68% -67.20% 1.98% -3.74% -25.44% 31.88% 3.18% -28.53%
Profit (Net Income) Margin		 2.19% 17.27% -3.43% -12.89% -127.89% -1.07% -7.00% -23.52% 31.28% -2.44% -31.53%
Tax Burden Percent		 -596.15% 95.41% 60.78% 82.53% 186.98% -25.54% 151.37% 109.21% 93.35% -98.52% 108.49%
Interest Burden Percent		 -37.41% 103.18% 77.81% 106.37% 101.78% 211.66% 123.63% 84.65% 105.08% 77.70% 101.86%
Effective Tax Rate		 0.00% 4.59% 0.00% 0.00% 0.00% 125.54% 0.00% 0.00% 6.65% 198.52% 0.00%
Return on Invested Capital (ROIC)		 -0.02% 7.25% -2.57% -4.51% -20.77% -0.31% -0.66% -6.84% 2.00% -1.73% -6.71%
ROIC Less NNEP Spread (ROIC-NNEP)		 2.14% 8.73% -1.08% -6.03% -75.65% -0.54% -3.42% -10.64% 28.32% 0.32% -21.69%
Return on Net Nonoperating Assets (RNNOA)		 0.30% 1.07% -0.21% -0.99% -13.94% -0.10% -0.77% -1.98% 3.53% 0.03% -2.61%
Return on Equity (ROE)		 0.29% 8.32% -2.78% -5.50% -34.71% -0.41% -1.44% -8.82% 5.53% -1.70% -9.32%
Cash Return on Invested Capital (CROIC)		 -13.12% -14.26% -13.45% -35.02% -6.69% -5.79% -1.78% -0.03% 1.26% 0.43% -1.39%
Operating Return on Assets (OROA)		 0.29% 5.09% -2.12% -4.13% -19.07% 0.54% -1.03% -6.77% 8.56% 0.82% -7.72%
Return on Assets (ROA)		 0.64% 5.01% -1.00% -3.63% -36.29% -0.29% -1.93% -6.26% 8.40% -0.63% -8.53%
Return on Common Equity (ROCE)		 0.28% 8.08% -2.69% -5.29% -33.19% -0.39% -1.36% -8.31% 5.14% -1.57% -8.50%
Return on Equity Simple (ROE_SIMPLE)		 -1.62% 0.00% 3.78% 0.76% -16.50% 0.00% -19.73% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -5.60 2,466 -748 -1,375 -6,340 -105 -211 -2,223 638 -571 -2,195
NOPAT Margin		 -0.04% 16.01% -5.88% -10.71% -47.73% -0.74% -1.66% -17.29% 4.67% -4.18% -16.17%
Net Nonoperating Expense Percent (NNEP)		 -2.16% -1.48% -1.49% 1.52% 54.89% 0.23% 2.76% 3.80% -26.32% -2.05% 14.99%
Return On Investment Capital (ROIC_SIMPLE)		 - 1.55% - - - -0.07% -0.13% -1.42% 0.39% -0.33% -1.29%
Cost of Revenue to Revenue		 57.49% 54.26% 59.00% 64.57% 84.97% 60.84% 63.12% 72.46% 61.78% 63.85% 60.62%
SG&A Expenses to Revenue		 9.46% 10.50% 12.23% 10.36% 10.41% 8.69% 9.29% 8.90% 8.27% 8.59% 7.65%
R&D to Revenue		 27.33% 25.88% 34.44% 33.03% 30.48% 27.18% 28.74% 28.65% 23.67% 23.54% 24.86%
Operating Expenses to Revenue		 42.56% 28.96% 49.40% 50.74% 83.21% 36.27% 39.26% 52.24% 33.22% 31.91% 62.48%
Earnings before Interest and Taxes (EBIT)		 139 2,702 -924 -1,884 -8,927 283 -474 -3,271 4,353 435 -3,874
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 2,586 5,215 1,627 685 -5,315 2,930 2,200 -258 7,345 3,462 -738
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.44 1.98 1.74 1.14 1.03 0.88 0.99 1.01 1.46 1.51 1.93
Price to Tangible Book Value (P/TBV)		 2.11 2.85 2.50 1.57 1.44 1.24 1.38 1.40 1.95 1.97 2.44
Price to Revenue (P/Rev)		 2.77 3.86 3.34 2.38 1.88 1.65 1.85 1.87 2.91 3.27 4.01
Price to Earnings (P/E)		 0.00 123.77 45.33 134.37 0.00 0.00 0.00 0.00 784.77 0.00 0.00
Dividend Yield		 2.80% 1.49% 1.14% 1.62% 2.09% 2.46% 2.20% 2.20% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.81% 2.21% 0.74% 0.00% 0.00% 0.00% 0.00% 0.13% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.36 1.81 1.58 1.11 1.02 0.91 0.99 1.01 1.40 1.46 1.81
Enterprise Value to Revenue (EV/Rev)		 3.19 4.28 3.88 2.80 2.36 2.18 2.43 2.47 3.23 3.51 4.33
Enterprise Value to EBITDA (EV/EBITDA)		 22.72 22.46 19.62 15.24 57.97 0.00 258.13 0.00 14.14 14.54 23.73
Enterprise Value to EBIT (EV/EBIT)		 0.00 321.10 190.29 4,671.07 0.00 0.00 0.00 0.00 193.81 177.77 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 1,134.05 130.45 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 11.58 20.21 17.79 13.38 13.16 13.98 12.50 12.99 20.14 19.12 23.33
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 110.20 340.81 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.46 0.45 0.47 0.44 0.48 0.48 0.47 0.48 0.40 0.37 0.36
Long-Term Debt to Equity		 0.44 0.43 0.43 0.40 0.44 0.44 0.42 0.42 0.38 0.35 0.34
Financial Leverage		 0.14 0.12 0.20 0.16 0.18 0.19 0.23 0.19 0.12 0.10 0.12
Leverage Ratio		 1.77 1.75 1.79 1.74 1.82 1.80 1.77 1.76 1.80 1.76 1.72
Compound Leverage Factor		 -0.66 1.81 1.39 1.85 1.85 3.82 2.19 1.49 1.89 1.37 1.75
Debt to Total Capital		 31.62% 30.94% 32.14% 30.57% 32.39% 32.26% 32.03% 32.43% 28.51% 26.94% 26.49%
Short-Term Debt to Total Capital		 1.48% 1.44% 2.81% 2.71% 2.43% 2.41% 3.35% 4.30% 1.53% 1.45% 1.18%
Long-Term Debt to Total Capital		 30.14% 29.50% 29.33% 27.86% 29.96% 29.85% 28.69% 28.13% 26.98% 25.49% 25.31%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 2.51% 2.75% 2.93% 3.00% 3.44% 3.72% 4.25% 5.03% 6.34% 6.98% 8.00%
Common Equity to Total Capital		 65.87% 66.31% 64.93% 66.43% 64.17% 64.03% 63.72% 62.54% 65.15% 66.08% 65.52%
Debt to EBITDA		 6.59 4.77 4.81 5.24 22.71 -685.08 100.30 -114.58 3.81 3.65 4.59
Net Debt to EBITDA		 2.45 1.78 2.29 1.77 9.34 -309.12 48.15 -54.56 0.57 0.05 0.38
Long-Term Debt to EBITDA		 6.28 4.55 4.39 4.78 21.01 -634.00 89.82 -99.38 3.61 3.46 4.39
Debt to NOPAT		 -19.27 240.99 31.96 -1.72 -7.55 -6.12 -6.57 -5.98 -172.48 -1,260.04 -12.74
Net Debt to NOPAT		 -7.15 90.02 15.23 -0.58 -3.10 -2.76 -3.15 -2.85 -25.75 -17.77 -1.06
Long-Term Debt to NOPAT		 -18.37 229.80 29.17 -1.57 -6.98 -5.66 -5.88 -5.19 -163.23 -1,192.45 -12.17
Altman Z-Score		 1.93 2.47 2.21 1.71 1.24 1.27 1.37 1.29 1.85 1.98 2.32
Noncontrolling Interest Sharing Ratio		 1.88% 2.93% 3.38% 3.85% 4.37% 4.71% 5.27% 5.78% 7.08% 7.71% 8.75%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.53 1.54 1.57 1.59 1.31 1.33 1.31 1.24 1.60 2.02 2.31
Quick Ratio		 0.97 1.01 0.91 1.01 0.77 0.72 0.75 0.67 1.06 1.31 1.37
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -12,870 -14,815 -19,391 -16,374 -8,023 665 5,056 6,224 2,475 9.58 -456
Operating Cash Flow to CapEx		 101.23% 69.06% -20.49% 40.34% 62.77% 54.25% 15.69% 57.75% 104.99% 122.94% 30.14%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.29 0.29 0.29 0.28 0.28 0.27 0.28 0.27 0.27 0.26 0.27
Accounts Receivable Turnover		 10.25 14.39 15.41 17.99 18.19 15.44 16.61 19.33 16.90 14.45 15.08
Inventory Turnover		 2.69 2.67 2.64 2.78 3.01 3.07 3.05 3.30 2.92 2.90 2.81
Fixed Asset Turnover		 0.63 0.61 0.60 0.57 0.55 0.52 0.51 0.50 0.51 0.50 0.50
Accounts Payable Turnover		 4.14 3.58 3.88 3.51 3.59 3.38 3.73 3.68 3.23 3.07 3.85
Days Sales Outstanding (DSO)		 35.60 25.36 23.69 20.29 20.06 23.65 21.97 18.88 21.59 25.27 24.20
Days Inventory Outstanding (DIO)		 135.60 136.67 138.28 131.27 121.16 119.05 119.71 110.75 124.86 126.06 129.89
Days Payable Outstanding (DPO)		 88.19 102.00 93.98 103.85 101.67 107.87 97.96 99.31 113.15 118.77 94.92
Cash Conversion Cycle (CCC)		 83.01 60.03 67.99 47.71 39.56 34.83 43.73 30.32 33.31 32.56 59.18
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 123,835 128,368 135,756 138,366 125,518 127,598 130,489 129,919 123,681 127,017 128,750
Invested Capital Turnover		 0.45 0.45 0.44 0.42 0.44 0.41 0.40 0.40 0.43 0.42 0.41
Increase / (Decrease) in Invested Capital		 12,864 17,281 18,643 14,999 1,683 -770 -5,267 -8,447 -1,837 -581 -1,739
Enterprise Value (EV)		 168,456 231,832 214,081 154,145 128,225 115,882 129,067 131,010 172,689 185,410 232,790
Market Capitalization		 146,434 209,054 184,298 131,008 102,239 87,554 98,334 98,974 155,384 172,674 215,434
Book Value per Share		 $24.31 $25.05 $24.98 $27.07 $23.28 $23.02 $23.04 $22.44 $24.30 $23.96 $22.30
Tangible Book Value per Share		 $16.54 $17.41 $17.41 $19.59 $16.58 $16.44 $16.51 $16.26 $18.18 $18.36 $17.66
Total Capital		 154,565 159,231 163,206 173,463 155,100 155,043 156,564 156,508 163,283 172,945 170,020
Total Debt		 48,879 49,266 52,450 53,029 50,236 50,011 50,151 50,757 46,553 46,585 45,031
Total Long-Term Debt		 46,591 46,978 47,869 48,334 46,471 46,282 44,911 44,026 44,057 44,086 43,027
Net Debt		 18,149 18,403 25,000 17,932 20,654 22,566 24,076 24,168 6,951 657 3,761
Capital Expenditures (CapEx)		 5,753 6,696 5,970 5,682 6,458 5,834 5,183 3,550 2,425 3,488 3,636
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -7,545 -7,530 -1,335 -5,776 -9,343 -6,675 -5,848 -6,066 -9,005 -2,804 4,487
Debt-free Net Working Capital (DFNWC)		 17,485 17,504 19,976 23,497 14,743 15,387 15,200 15,140 21,930 34,612 37,276
Net Working Capital (NWC)		 15,197 15,216 15,395 18,802 10,978 11,658 9,960 8,409 19,434 32,113 35,272
Net Nonoperating Expense (NNE)		 -316 -194 -311 279 10,649 48 676 801 -3,632 -238 2,086
Net Nonoperating Obligations (NNO)		 18,149 18,403 25,000 17,932 20,654 22,566 24,076 24,168 6,951 657 3,761
Total Depreciation and Amortization (D&A)		 2,447 2,513 2,551 2,569 3,612 2,647 2,674 3,013 2,992 3,027 3,136
Debt-free, Cash-free Net Working Capital to Revenue		 -14.27% -13.89% -2.42% -10.48% -17.22% -12.57% -11.02% -11.43% -16.85% -5.31% 8.35%
Debt-free Net Working Capital to Revenue		 33.08% 32.28% 36.16% 42.63% 27.18% 28.98% 28.66% 28.53% 41.04% 65.49% 69.33%
Net Working Capital to Revenue		 28.75% 28.06% 27.87% 34.11% 20.24% 21.95% 18.78% 15.85% 36.37% 60.76% 65.61%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.07 $0.64 ($0.09) ($0.38) ($3.88) ($0.03) ($0.19) ($0.67) $0.90 ($0.10) ($0.73)
Adjusted Weighted Average Basic Shares Outstanding		 4.20B 4.19B 4.24B 4.27B 4.29B 4.28B 4.34B 4.37B 4.51B 4.53B 5.08B
Adjusted Diluted Earnings per Share		 $0.07 $0.64 ($0.09) ($0.38) ($3.88) ($0.03) ($0.19) ($0.67) $0.90 ($0.10) ($0.73)
Adjusted Weighted Average Diluted Shares Outstanding		 4.23B 4.21B 4.24B 4.27B 4.29B 4.28B 4.34B 4.37B 4.53B 4.53B 5.08B
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 4.22B 8.46B 4.26B 4.28B 4.31B 4.33B 4.36B 4.38B 4.77B 5.00B 5.03B
Normalized Net Operating Profit after Tax (NOPAT)		 566 1,377 -505 -715 -2,405 328 -102 -900 801 385 654
Normalized NOPAT Margin		 3.99% 8.94% -3.97% -5.57% -18.10% 2.30% -0.80% -7.00% 5.87% 2.82% 4.82%
Pre Tax Income Margin		 -0.37% 18.10% -5.65% -15.62% -68.40% 4.20% -4.63% -21.53% 33.50% 2.47% -29.06%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 -247.27% 184.36% 52.55% 240.61% -12.95% -8.31% -5.44% -2.55% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -247.27% 184.36% 52.55% 240.61% -12.95% -8.31% -5.44% -2.55% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Intel (INTC) has shown some cash-flow strength at the end of 2025, but profitability remains volatile and the company carries a meaningful debt load. Below are the top trends from Intel’s quarterly statements over the last four years, focusing on cash flow, liquidity, and key profitability indicators.

  • Q4 2025 operating cash flow was about $4.29 billion, up from roughly $3.16 billion in Q4 2024, signaling improved cash generation from core operations.
  • Estimated free cash flow in Q4 2025 was roughly $0.80 billion (about $4.29B of cash from operations less around $3.49B of capital expenditures), indicating positive cash after sustaining capex.
  • Financing activity in Q4 2025 produced about $5.85 billion in net cash, supported by a substantial equity issuance (about $14.07 billion), bolstering liquidity despite ongoing investing.
  • Intel’s equity issuance in Q4 2025 (common equity around $14.07 billion) provided a large cash infusion, helping liquidity and balance-sheet flexibility.
  • As of the latest quarter in 2025 (Q3 data referenced), Intel held substantial liquidity: roughly $11.4 billion in cash and equivalents and about $19.8 billion in short-term investments, totaling ~ $31 billion in liquid assets.
  • Revenue has trended lower over the four-year window: about $15.41 billion in 2023 Q4, $14.26 billion in 2024 Q4, and $13.67 billion in 2025 Q4, indicating some top-line pressure despite cash-flow strength.
  • Net income and earnings per share have been negative in most quarters over the period (e.g., Q4 2025: net income around -$333 million; EPS around -$0.10), underscoring ongoing profitability volatility even as cash flow improves.
  • Net income attributable to common shareholders in Q4 2025 was -$591 million, highlighting continued profitability challenges at the bottom line despite positive operating cash flow.
  • The company faces a sizable balance-sheet debt load: long-term debt typically in the mid-$40 billions (e.g., around $44–46 billion in recent quarters), with total liabilities well over $80 billion, indicating a heavy leverage backdrop even as liquidity improves.
  • Investing cash flow has been broadly negative across quarters (net cash from investing activities frequently negative due to capex and acquisitions), reflecting ongoing capital deployment to support technology and capacity initiatives.
05/21/26 01:03 AM ETAI Generated. May Contain Errors.

Intel Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Intel's fiscal year ends in December. Their fiscal year 2025 ended on December 27, 2025.

Intel's net income appears to be on a downward trend, with a most recent value of $26 million in 2025, falling from $11.42 billion in 2015. The previous period was -$19.23 billion in 2024. See where experts think Intel is headed by visiting Intel's forecast page.

Intel's total operating income in 2025 was -$2.21 billion, based on the following breakdown:
  • Total Gross Profit: $18.38 billion
  • Total Operating Expenses: $20.59 billion

Over the last 10 years, Intel's total revenue changed from $55.36 billion in 2015 to $52.85 billion in 2025, a change of -4.5%.

Intel's total liabilities were at $85.07 billion at the end of 2025, a 7.0% decrease from 2024, and a 115.5% increase since 2015.

In the past 10 years, Intel's cash and equivalents has ranged from $3.02 billion in 2018 to $15.31 billion in 2015, and is currently $14.27 billion as of their latest financial filing in 2025.

Over the last 10 years, Intel's book value per share changed from 12.94 in 2015 to 23.96 in 2025, a change of 85.1%.


Related Companies

Financial statements for NASDAQ:INTC last updated on 4/28/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel